Changeflow GovPing Healthcare & Life Sciences Abbott Analyte Monitoring Systems Patent Public...
Routine Rule Added Final

Abbott Analyte Monitoring Systems Patent Publication EP4153048A1

Favicon for changeflow.com EPO Patent Bulletin - Diagnosis & Surgery (A61B)
Published
Detected
Email

Summary

The European Patent Office published patent application EP4153048A1 on April 15, 2026, titled 'Systems, Devices, and Methods of Analyte Monitoring.' The applicant is Abbott Diabetes Care Inc.; inventors are Kumar and Dunn. The application covers A61B 5/00 (measuring for diagnosis) and G16H 50/20 (computing for health care). Designated states cover EU member states plus CH, LI, NO, TR, and GB.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Diagnosis & Surgery (A61B) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 66 changes logged to date.

What changed

The EPO published patent application EP4153048A1 for Abbott Diabetes Care's analyte monitoring systems and methods. The application entered the European patent register on April 15, 2026 and is now publicly available for inspection and potential opposition. Key IPC classifications include A61B 5/00 and G16H 50/20, indicating medical measurement and health informatics components.

Medical device manufacturers and diagnostic developers working in continuous glucose monitoring or similar analyte detection should review the published claims for potential freedom-to-operate implications. The patent's broad coverage of systems and methods for analyte monitoring may capture commercially relevant configurations in the diabetes care and point-of-care diagnostics markets.

Archived snapshot

Apr 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

SYSTEMS, DEVICES, AND METHODS OF ANALYTE MONITORING

Publication EP4153048A1 Kind: A1 Apr 15, 2026

Applicants

Abbott Diabetes Care Inc.

Inventors

KUMAR, Panganamala Ashwin, DUNN, Timothy C.

IPC Classifications

A61B 5/00 20060101AFI20240626BHEP A61B 5/145 20060101ALI20240626BHEP G16H 50/20 20180101ALI20240626BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Diagnosis & Surgery (A61B)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Medical device makers Manufacturers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent publication IP registration
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices

Get alerts for this source

We'll email you when EPO Patent Bulletin - Diagnosis & Surgery (A61B) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!